Aurora Spine (ASG) Price & Analysis

Compare

6 Followers

ASG Stock Chart & Stats

C$0.28

>-C$0.01(-1.05%)

At close: Jan 07 4:00 PM EST

C$0.28

>-C$0.01(-1.05%)

Day’s Range― - ―

52-Week RangeC$0.24 - C$0.40

Previous CloseN/A

Volume6.50K

Average Volume (3M)30.19K

Market Cap

C$23.81M

Enterprise ValueC$19.49M

Total Cash (Recent Filing)C$926.33K

Total Debt (Recent Filing)C$3.59M

Price to Earnings (P/E)―

Beta0.41

Next Earnings

May 04, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding78,054,950

10 Day Avg. Volume38,837

30 Day Avg. Volume30,190

Financial Highlights & Ratios

PEG Ratio0.46

Price to Book (P/B)4.78

Price to Sales (P/S)1.20

P/FCF Ratio78.91

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthSustained revenue growth indicates expanding product adoption and market traction for Aurora Spine's implants and tools. Over the next 2–6 months this trend supports scale benefits, helps justify continued investment in R&D and commercialization, and underpins longer-term revenue stability.

Healthy Gross MarginA gross margin above 50% suggests structurally favorable product economics and pricing power in core spinal implant lines. This margin cushion supports investment in product development and sales while insulating operating profit from modest cost pressures, aiding margin sustainability over time.

Moderate LeverageA debt-to-equity around 0.62 denotes manageable leverage and an improvement versus prior periods, giving the company financial flexibility. Moderate debt levels reduce bankruptcy risk and allow borrowing for targeted growth initiatives without immediate balance-sheet stress.

Bears Say

Negative ProfitabilityPersistent negative net income and EBIT margins indicate operational inefficiencies or high fixed costs relative to current sales. Over months this limits retained earnings, reduces ability to self-fund growth, and requires either improved margins or external capital for sustained commercialization.

Weak Cash GenerationLow operating cash conversion and negative free cash flow signal constrained liquidity and poor cash generation from operations. This structural cash weakness increases reliance on financing, can delay product launches or sales expansion, and raises execution risk over the medium term.

Limited Scale And ResourcesA very small employee base limits commercial reach, clinical support and rapid scaling in hospital channels. Over several months this can slow adoption, strain R&D and regulatory initiatives, and increase dependence on partners or distributors to achieve broader market penetration.

Aurora Spine News

Aurora Spine Bolsters IP Portfolio With Two New U.S. Patents

Aurora Spine ( ($TSE:ASG) ) just unveiled an announcement. Aurora Spine has secured two new U.S. patents that...

2M ago

Aurora Spine Reports Record Q3 2025 Results Amid Product Launches

Aurora Spine ( ($TSE:ASG) ) just unveiled an announcement. Aurora Spine Corporation announced record financial results for the...

3M ago

Aurora Spine to Showcase Innovations at NASS 2025

Aurora Spine ( ($TSE:ASG) ) has provided an announcement. Aurora Spine Corporation announced its participation in the 2025...

3M ago

Aurora Spine Unveils Aurora Biologics to Enhance Spinal Fusion Success

Aurora Spine ( ($TSE:ASG) ) just unveiled an announcement. Aurora Spine has launched Aurora Biologics, a new division...

4M ago

Aurora Spine Proposes Extension of Warrant Expiry Date

Aurora Spine ( ($TSE:ASG) ) has shared an update. Aurora Spine Corporation has announced a proposed extension of...

4M ago

Aurora Spine Launches Innovative Bone Density-Matched Lumbar Fusion Device

Aurora Spine ( ($TSE:ASG) ) has shared an update. Aurora Spine has launched the DEXA-L™ Anterior Lumbar Interbody...

5M ago

Aurora Spine Reports Record Q2 2025 Financial Results and Product Milestones

The latest announcement is out from Aurora Spine ( ($TSE:ASG) ). Aurora Spine Corporation reported a record second...

6M ago

Aurora Spine to Showcase Innovations at ASPN Conference

Aurora Spine ( ($TSE:ASG) ) has provided an update. Aurora Spine announced its participation in the 7th Annual...

7M ago

Aurora Spine Launches AERO Lumbar Fusion System with Initial Surgeries

Aurora Spine ( ($TSE:ASG) ) has shared an announcement. Aurora Spine has announced the initial surgeries using its...

8M ago

Aurora Spine Celebrates Milestone with DEXA-C System and Prepares for New Product Launch

Aurora Spine ( ($TSE:ASG) ) just unveiled an update. Aurora Spine has achieved a significant milestone with its...

8M ago

ASG FAQ

What was Aurora Spine Corp’s price range in the past 12 months?

Aurora Spine Corp lowest stock price was C$0.23 and its highest was C$0.40 in the past 12 months.

What is Aurora Spine Corp’s market cap?

Aurora Spine Corp’s market cap is C$23.81M.

When is Aurora Spine Corp’s upcoming earnings report date?

Aurora Spine Corp’s upcoming earnings report date is May 04, 2026 which is in 70 days.

How were Aurora Spine Corp’s earnings last quarter?

Aurora Spine Corp released its earnings results on Nov 18, 2025. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.

Is Aurora Spine Corp overvalued?

According to Wall Street analysts Aurora Spine Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aurora Spine Corp pay dividends?

Aurora Spine Corp does not currently pay dividends.

What is Aurora Spine Corp’s EPS estimate?

Aurora Spine Corp’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aurora Spine Corp have?

Aurora Spine Corp has 78,054,950 shares outstanding.

What happened to Aurora Spine Corp’s price movement after its last earnings report?

Aurora Spine Corp reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.677%.

Which hedge fund is a major shareholder of Aurora Spine Corp?

Currently, no hedge funds are holding shares in TSE:ASG

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aurora Spine Corp

Aurora Spine (ASG) is a medical device company focused on developing innovative spinal implants and surgical solutions. The company operates in the orthopedic and spinal surgery sectors, providing a range of products that include interbody fusion devices, spinal fixation systems, and minimally invasive surgical tools. Aurora Spine aims to improve patient outcomes and enhance surgical efficiency through its advanced technology and commitment to research and development.